Citeline’s Chief Clinical Officer Featured in Rewriting Cancer Series

NEW YORK – June 23, 2026 – Cancer remains one of the greatest global health challenges in the world, with many people affected in some way. The Rewriting Cancer series is returning for a second brand feature celebrating the stories of the people rewriting what cancer means — including Citeline’s own Madeline Naylor, Chief Clinical Officer — from early detection and education, to closing care gaps worldwide and finding ways to continue living fully.

Presented by the Union for International Cancer Control (UICC) and produced for UICC by BBC StoryWorks Commercial Productions, Rewriting Cancer showcases ordinary people doing extraordinary things in a bid to improve lives affected by cancer. The latest series explores the changing face of cancer and how it is detected, treated and understood across the world:

• Protecting communities – how education and early detection can help cancer outcomes
• Closing the gap – transforming access to cancer care
• Redefining care – Improving and innovating how cancer is treated

“Working with BBC StoryWorks was an unforgettable experience,” says Naylor, whose experience losing her father to esophageal cancer was highlighted in the film and is what drives her passion for connecting patients to clinical trials. ”From start to finish, the crew was professional, thoughtful, and wonderful to work with. My son still proudly talks about being a ‘movie star’ for a day.

“I’m grateful for the opportunity to share my story, honor my father’s legacy, and represent the exceptional team at Citeline. It was a privilege to showcase the meaningful work being done every day to support patients and healthcare professionals through clinical trial recruitment. Thank you to Citeline and the BBC StoryWorks team for helping tell my story!”

“This new cancer series presented by UICC shows once again how important it is to hear from people affected by cancer,” says Cary Adams, CEO of UICC, “and how their experience can inform decisions that shape how health care is delivered.”

The new series, Rewriting Cancer, launches June 23 and is available online at www.rewritingcancer.com.

For more information on how Citeline PatientMatch accelerates the connection of treatments to patients and patients to treatments, and watch Naylor’s moving video, visit Citeline.com.

About Citeline

Citeline, backed by the strength of Norstella's AI engine, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical-, commercial-, and regulatory-related decisions and create real-world opportunities for growth. 

Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical, and medtech industries, covering them all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts, and more. For more information on one of the world’s most trusted health science partners, visit  Citeline and follow on LinkedIn and X.

About UICC

UICC is the oldest and largest global membership organization dedicated to taking action on cancer. UICC’s mission is to unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity, and ensure that cancer control remains a priority on the global health and development agenda.

Founded in 1933 and based in Geneva, Switzerland, UICC has more than 1,100 member organizations in over 170 countries and territories. The membership includes the world’s major cancer leagues and societies, research institutes, treatment centers, hospitals, ministries of health, public health agencies, and patient support groups.

Citeline PR contact:
Diffusion PR for Citeline
[email protected]
(213) 318-4500